GBC Blog

NIH’s 1-million-volunteer Precision Medicine Study Announces First Pilot Projects By Jocelyn Kaiser, Feb. 25, 2016  President Obama’s huge 1-million-person long-term health study is getting started. Today, the White House and National Institutes of Health (NIH) announced several pilot projects, including one to work out how to recruit hundreds of thousands of volunteers online. A Google company,…

View Entire Article at: http://www.captodayonline.com/community-hospitals-keep-time-tissue-handling/ February 2016 by Kevin B. O’Reilly, CAP TODAY Senior Editor – The great promise of genomics and actionable cancer biomarkers relies on cancer tissues being handled in the right way so they are suitable for study. Reducing cold ischemia time and the total time that biospecimens spend in formalin is key to…

Asterand Bioscience Has Been Awarded a Five-Year, $6.5M Contract from the National Institutes of Health (NIH)
DETROIT–(Business Wire)–Asterand Bioscience is pleased to announce that is has been awarded a five-year, $6.5M contract from the National Institutes of Health (NIH) to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).…

https://irlocator.isber.org/ The International Repository Locator (IRL) is an initiative by ISBER to help investigators locate biospecimen and data repositories by developing a directory of repository information that can be searched online. The International Repository Locator also seeks to increase the profile of research and biobanking activities being supported by individual repositories amongst key global stakeholders…

https://www.genomeweb.com/molecular-diagnostics/hopkins-lab-cepheid-developing-methylated-dna-panel-breast-cancer-dx

http://www.epigenomics.com/en/news-investors/news-media/press-releases/latest-news/article/fda-fordert-weitere-daten-vor-zulassung-von-epigenomics-bluttest-zum-darmkrebs-screening.html

http://www.eurekalert.org/pub_releases/2015-10/vari-nsv102915.php

Curetis and Acumen to Collaborate on Unyvero Sepsis Test and ASEAN Distribution Curetis licenses Acumen’s proprietary sepsis biomarker panel for use with Unyvero Platform Diagnostics Development (DxD) Hub in Singapore to support Acumen in development and clinical validation of the panel Acumen to distribute Unyvero product line in ASEAN countries [LINK] Holzgerlingen, Germany and Singapore,…

Curetis Unyvero (Video):  In vitro diagnostic for rapid pathogen and antibiotic resistance profiling. Select link below to view video : https://www.youtube.com/watch?v=khQETD4qZio

Curetis Enters into Distribution Agreement to Expand Commercial Activities into Greater China Exclusive Unyvero distribution agreement with Beijing Clear Biotech Co., Ltd. for Mainland China, Hong Kong and Taiwan Clinical trials for CFDA regulatory approval in preparation [Link] Holzgerlingen, Germany, September 25, 2015 — Curetis AG, a developer of next-level molecular diagnostic solutions, today announced…